{"id":48692,"date":"2022-09-22T14:01:51","date_gmt":"2022-09-22T12:01:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/"},"modified":"2022-09-22T14:01:51","modified_gmt":"2022-09-22T12:01:51","slug":"recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/","title":{"rendered":"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit"},"content":{"rendered":"
\n

MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics<\/a>, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that David Lockhart, Ph.D, President and Chief Scientific Officer of ReCode Therapeutics, will present a company overview at 8:00 a.m. ET on Thursday, September 29, 2022 at the upcoming Jefferies Cell and Genetic Medicine Summit being held in New York, NY.\n<\/p>\n

<\/a><\/p>\n

\nAbout ReCode Therapeutics<\/b>\n<\/p>\n

\nReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode\u2019s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. The SORT LNP platform is the foundation for ReCode\u2019s pipeline of disease-modifying mRNA and gene correction therapeutics. ReCode\u2019s lead programs are focused on primary ciliary dyskinesia and cystic fibrosis. ReCode is leveraging its SORT LNP platform and nucleic acid technologies to expand its pipeline with therapeutics that use mRNA-mediated replacement and gene correction in target organs with precision targeting of disease-relevant cells. For more information, visit www.recodetx.com<\/a> and follow us on Twitter @ReCodeTx<\/a> and on LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/span><\/b>
Sarah McCabe
\n
Stern IR
\n
sarah.mccabe@sternir.com<\/a>
IR@recodetx.com<\/a>\n<\/p>\n

\nMedia Contact:<\/span><\/b>
Tara Cooper
\n
The Grace Communication Group
\n
tara@gracegroup.us<\/a>
650-303-7306\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that David Lockhart, Ph.D, President and Chief Scientific Officer of ReCode Therapeutics, will present a company overview at 8:00 a.m. ET on Thursday, September 29, 2022 at the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48692","6":"format-standard","7":"category-industry"},"yoast_head":"\nReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that David Lockhart, Ph.D, President and Chief Scientific Officer of ReCode Therapeutics, will present a company overview at 8:00 a.m. ET on Thursday, September 29, 2022 at the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-22T12:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220922005033\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit\",\"datePublished\":\"2022-09-22T12:01:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/\"},\"wordCount\":239,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005033\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/\",\"name\":\"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005033\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\",\"datePublished\":\"2022-09-22T12:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005033\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220922005033\\\/en\\\/1498350\\\/21\\\/ReCode_Logo_Primary_Web%402000px.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/","og_locale":"en_US","og_type":"article","og_title":"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit - Pharma Trend","og_description":"MENLO PARK, Calif. & DALLAS–(BUSINESS WIRE)–ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that David Lockhart, Ph.D, President and Chief Scientific Officer of ReCode Therapeutics, will present a company overview at 8:00 a.m. ET on Thursday, September 29, 2022 at the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-22T12:01:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220922005033\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit","datePublished":"2022-09-22T12:01:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/"},"wordCount":239,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005033\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/","url":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/","name":"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220922005033\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","datePublished":"2022-09-22T12:01:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220922005033\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220922005033\/en\/1498350\/21\/ReCode_Logo_Primary_Web%402000px.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/recode-therapeutics-to-present-at-jefferies-cell-and-genetic-medicine-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48692"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48692\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}